Minisymposium No. 50 in the series Frontiers in Medicine

//Minisymposium No. 50 in the series Frontiers in Medicine

Minisymposium No.50 in the series Frontiers in Medicine 

Lipid mobilization from adipose tissue – novel aspects on an old story

Nobel Forum

May 22nd-23rd, 2012

Read more for full programme


Tuesday 22nd of May
Chair: Peter Arner, Sweden
09.00-09.20 Introduction-the history of lipolysis, Peter Arner, Sweden
09.20-10.05 Key Note Lecture 1. Regulation of regional adipose tissue lipolysis and direct FFA storage in vivo–implications for body fat distribution in humans. Michael Jensen, USA
10.05-10.25 Oxygen consumption by adipose tissue. Leanne Hodson, UK
10.25-10.40 Coffee
10.40-11.10 Function of abdominal and gluteofemoral adipose tissue. Fredrik Karpe, UK
11.10-11.30 Wnt signalling determining regional adipose tissue cellularity. Costas Christodoulides, UK
11.30-12.00 Enzymes and regulators of lipolysis in energy metabolism and lipid signalling Rudolph Zechner, Austria

12.00-13.00 Lunch

Chair: Mikael Rydén, Sweden
13.00-13.45 Key Note Lecture 2. Cell Biology of Lipid Droplet formation and Growth. Tobias Walther, USA
13.45-14.15 Hormone-sensitive lipase – novel roles for an old enzyme. Cecilia Holm, Sweden
14.15-14.35 Novel aspects of Adiponutrin in lipid metabolism. Helena Jones, Sweden
14.35-15.00 Coffee
15.00-15.30 Adipose tissue lipolysis and insulin resistance. Dominique Langin, France
15.30-15.50 Roles of acylglycerol lipases in skeletal muscle. Cedric Moro, France
15.50-16.00 General information

Dinner for invited participants

Wednesday 23rd of May
Chair: Max Lafontan, France
09.00-09.45 Key Note Lecture 3. Modelling in vivo data in human adipose tissue research. Samuel Bernard, France
09.45-10.15 Turnover of human fat cells and their lipids. Kirsty Spalding, Sweden
10.15-10.45 LXR and human fat cell metabolism. Jurga Laurencikiene, Sweden
10.45-11.10 Coffee
11.10-11.30 MicroRNAs as human adipocyte regulators. Agne Kulyte, Sweden
11.30-12.00 Lipolysis in human cancer cachexia and chronic kidney disease. Mikael Rydén, Sweden
12.00-12.10 Concluding remarks (Peter Arner), end of meeting

Hosted by: Peter Arner and Mikael Rydén, Dept of Medicine (H7). Registrations by e-mail to before the 8th of May.